COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study
2020; Wiley; Volume: 73; Issue: 6 Linguagem: Inglês
10.1002/art.41619
ISSN2326-5205
AutoresKristin M. D’Silva, April Jorge, A. N. Cohen, Natalie McCormick, Yuqing Zhang, Zachary S. Wallace, Hyon K. Choi,
Tópico(s)Dermatological and COVID-19 studies
ResumoPatients with systemic autoimmune rheumatic diseases (ARDs) continue to be concerned about risks of severe coronavirus disease 2019 (COVID-19) outcomes. This study was undertaken to evaluate the risks of severe outcomes in COVID-19 patients with systemic ARDs compared to COVID-19 patients without systemic ARDs.
Referência(s)